Broadleaf Partners, LLC Amgen Inc Transaction History

Broadleaf Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $2.37 Million - $2.77 Million	-13,970 Closed	0 $0
Q4 2017 Jan 12, 2018	BUY	$168.79 - $188.59 $2.36 Million - $2.63 Million	13,970	13,970 $2.43 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Broadleaf Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Broadleaf Partners, LLC with notifications on news.